These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25911604)

  • 1. Is there any effect of first-day usage of a totally implantable venous access device on complications?
    Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
    Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.
    El-Balat A; Schmeil I; Karn T; Holtrich U; Mavrova-Risteska L; Rody A; Youssef A; Hanker LC
    In Vivo; 2018; 32(5):1275-1281. PubMed ID: 30150457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.
    Lin WY; Lin CP; Hsu CH; Lee YH; Lin YT; Hsu MC; Shao YY
    Br J Cancer; 2017 Sep; 117(7):932-937. PubMed ID: 28787431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
    Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F
    Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
    Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
    World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
    Kim JT; Oh TY; Chang WH; Jeong YK
    Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
    Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
    Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications with totally implantable venous access device. A retrospective of 116 cases].
    Talfer S; Conessa C; Hervé S; Roguet E; de Rotalier P; Poncet JL
    Presse Med; 2003 Aug; 32(27):1263-8. PubMed ID: 14506448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.
    Liberale G; El Houkayem M; Viste C; Bouazza F; Moreau M; El Nakadi I; Veys I
    Support Care Cancer; 2016 Dec; 24(12):5035-5040. PubMed ID: 27495928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest.
    Surov A; Rusner C; Weigand K; John E; Spielmann RP; Behrmann C
    Acta Radiol; 2012 Nov; 53(9):1035-9. PubMed ID: 23028172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
    Toro A; Mannino M; Cappello G; Celeste S; Cordio S; Di Carlo I
    Ann Vasc Surg; 2012 Nov; 26(8):1127.e9-1127.e13. PubMed ID: 22951064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
    Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H
    Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
    Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
    Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
    Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
    Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable.
    Sun X; Zhang Y; Yang C; Zhou Y; Bai X; Zheng W; Jin Y
    Geriatr Gerontol Int; 2019 Mar; 19(3):218-221. PubMed ID: 30724007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
    Burbridge B; Goyal K
    J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period.
    Kariyawasam HH; Pepper JR; Hodson ME; Geddes DM
    Respir Med; 2000 Dec; 94(12):1161-5. PubMed ID: 11192950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High pressure versus standard port system: comparison of implantation and complications.
    Plumhans C; Ocklenburg C; Verburg FA; Günther RW; Behrendt FF
    J Med Imaging Radiat Oncol; 2012 Oct; 56(5):532-7. PubMed ID: 23043572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.